Back to top
more

Labcorp (LH)

(Real Time Quote from BATS)

$236.91 USD

236.91
154,863

+2.53 (1.08%)

Updated Nov 7, 2024 01:46 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 22% (54 out of 251)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Intuitive Surgical (ISRG) Posts Robust Preliminary Q4 Results

by Zacks Equity Research

Intuitive Surgical (ISRG) posts solid fourth-quarter and full-year 2021 results driven primarily by da Vinci procedure volume growth.

Medtronic's (MDT) DTM SCS Endurance Therapy Study Data Positive

by Zacks Equity Research

Medtronic's (MDT) DTM SCS endurance therapy offers meaningful clinical benefits by reducing pain, improving quality of life and offering meaningful device longevity for patients.

LabCorp (LH) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, LabCorp (LH) closed at $276.08, marking a -0.62% move from the previous day.

Abbott (ABT) Gets FDA Nod for New Cardiac Mapping System

by Zacks Equity Research

Abbott's (ABT) EnSite X EP System with EnSite Omnipolar Technology offers a 360-degree view of the heart, regardless of catheter orientation, for cardiac mapping without compromise.

Bio Rad's (BIO) Product Launches Aid, Forex Woes Persist

by Zacks Equity Research

Bio Rad's (BIO) strength in its key product lines across major geographic regions buoys optimism.

Quest Diagnostics (DGX) Posts Preliminary Q4 & 2021 Results

by Zacks Equity Research

Quest Diagnostics (DGX) posts preliminary fourth-quarter and full-year results, reflecting an increase in COVID-19 testing services and a steady recovery in the company's base testing volumes.

David Bartosiak headshot

Bear of the Day: Cardinal Health (CAH)

by David Bartosiak

Earnings are not as healthy as they could be.

    Here's Why You Should Retain Thermo Fisher (TMO) Stock for Now

    by Zacks Equity Research

    Investors are optimistic about Thermo Fisher's (TMO) strong end-market growth and focus on international regions.

    LabCorp (LH) Gains But Lags Market: What You Should Know

    by Zacks Equity Research

    LabCorp (LH) closed at $291.94 in the latest trading session, marking a +0.11% move from the prior day.

    Why LabCorp (LH) is Poised to Beat Earnings Estimates Again

    by Zacks Equity Research

    LabCorp (LH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

    DexCom (DXCM) Posts Solid Preliminary Q4 and 2021 Revenues

    by Zacks Equity Research

    DexCom (DXCM) posts solid fourth-quarter and full-year 2021 revenue data on the back of resilience shown in the face of the COVID-19 induced challenges.

    Here's Why You Should Retain AmerisourceBergen (ABC) Stock

    by Zacks Equity Research

    AmerisourceBergen (ABC) continues to gain traction from the robust pharmaceutical segment. However, stiff competition is a woe.

    Here's Why You Should Retain Intuitive Surgical (ISRG) Stock

    by Zacks Equity Research

    Intuitive Surgical (ISRG) continues to gain traction from improving the adoption of the da Vince Surgical System. Higher production costs are a woe.

    PacBio's (PACB) Sequel IIe Boosts Radboudumc's Sequencing Ability

    by Zacks Equity Research

    PacBio's (PACB) sequencing system enhances Radboudumc's SMRT sequencing capability through the addition of two new PacBio Sequel IIe systems.

    BD (BDX) Product Gets FDA Nod, Patient Outcome to Get a Boost

    by Zacks Equity Research

    Regulatory clearance for BD's (BDX) Kiestra IdentifA system is expected to lead to better patient management via automated sample processing and MALDI target preparation.

    Here's Why You Should Retain CVS Health (CVS) Stock for Now

    by Zacks Equity Research

    Investors are optimistic about CVS Health (CVS), owing to consistent improvement in its consumer-centric digital solutions and raised guidance.

    NuVasive (NUVA) Gets FDA Nod for Attrax Putty Expanded Use

    by Zacks Equity Research

    NuVasive's (NUVA) Attrax Putty is the first and only synthetic biologic to receive 510(k) indications for use in interbody fusions of the thoracolumbar spine.

    Nitish Marwah headshot

    4 Momentum Picks Screened on Driehaus Strategy

    by Nitish Marwah

    COWN, LH, BBWI, and ARCB qualified as the momentum picks for the day, using the Driehaus strategy.

    Stryker (SYK) to Boost Digital Capabilities With New Buyout

    by Zacks Equity Research

    Stryker (SYK) inks a deal with Vocera to enhance its digital healthcare offerings.

    Thermo Fisher (TMO) Completes Buyout of PeproTech for $1.85B

    by Zacks Equity Research

    Thermo Fisher's (TMO) recent acquisition will boost its capabilities to serve in the high-growth cell and gene therapy market.

    Here's Why You Should Retain Baxter (BAX) Stock For Now

    by Zacks Equity Research

    Investors continue to be optimistic about Baxter (BAX) due to its strong product portfolio.

    Here's Why You Should Retain Stryker (SYK) Stock Right Now

    by Zacks Equity Research

    Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure remains a concern.

    PacBio (PACB) Ties Up to Boost Rare Disease Diagnosis in Canada

    by Zacks Equity Research

    PacBio's (PACB) recent partnership with Care4Rare, with regard to a study, has the potential to enhance rare disease diagnosis within Canada.

    Best Value Stocks to Buy for January 6th

    by Zacks Equity Research

    M, LH, and SEKEY made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 6, 2022

      LabCorp (LH) Stock Moves -1.25%: What You Should Know

      by Zacks Equity Research

      LabCorp (LH) closed at $286.57 in the latest trading session, marking a -1.25% move from the prior day.